<DOC>
	<DOC>NCT00911924</DOC>
	<brief_summary>Prospective, unmasked, evaluation of the iStent in patients that have primary open-angle glaucoma (OAG). Stent implantation in one eye will be used for analysis, with medication added at 6 months, as required.</brief_summary>
	<brief_title>A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma</brief_title>
	<detailed_description>One hundred patients will be enrolled in the study at up to 21 sites; follow-up is through 1 year.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<criteria>Diagnosis of primary openangle glaucoma Male or female at least 18 years of age and able to provide written informed consent Mean IOP (at baseline visit after washout of any medications) must be at least 22 mm Hg and no greater than 38 mm Hg Likely to be available and willing to attend followup visits Angle closure glaucoma Secondary glaucomas Prior glaucoma procedures Elevated episcleral venous pressure from history of active thyroid orbitopathy, carotidcavernous fistula, orbital tumors, or orbital congestive disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>primary open angle glaucoma (POAG)</keyword>
	<keyword>OAG</keyword>
	<keyword>glaucoma</keyword>
</DOC>